FGF1 and type 1 diabetes mellitus: To test this hypothesis, we treated 6-h fasted T1D rats with 10 μg ICV FGF1 and observed >50% reductions in plasma glucose, NEFA and glycerol concentrations and increased plasma lactate concentrations despite unchanged plasma insulin concentrations (Fig. 5a–e).